Inflammation Markers in Fluid Aspirate From a Scarred Uterine vs. a Normal Uterine Cavity

Launched by HADASSAH MEDICAL ORGANIZATION · Mar 20, 2024

Keywords

ClinConnect Summary

This clinical trial is studying the differences in inflammation markers found in the fluid from the uterine cavities of women who have had a cesarean section compared to those with a normal, intact uterus. The goal is to understand how these differences might relate to issues with infertility, especially when the embryo does not implant properly.

Women who are experiencing infertility and are going to have a special ultrasound test called a hydrosonography may be eligible to participate. This test helps doctors assess the health of the uterus and fallopian tubes. If you qualify, you will undergo a procedure where a small amount of sterile salt solution is gently flushed into the uterus, and then the fluid will be collected for analysis. This trial is currently recruiting women aged 18 to 49, but certain conditions, like previous surgeries or specific medications, may prevent some from participating. Your involvement could help improve understanding of infertility related to uterine health.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • - Patients suffering from infertility and assigned for a hydrosonography exam for assessment of the integrity of the uterus and fallopian tubes.
• Exclusion Criteria:
• • 1. Patients with hydrosalpinx/pyosalpinx/sactosalpinx
• • 2. Patients who went through surgical correction of a niche
• • 3. Hormonal treatment- estrogens or progestins.
• • 4. Immunosuppressive/immunomodulating medication